Press releases

28 October, 2022
News
Corporate Information
Other Corporate Information
English
IR
Ziccum har haft ett mycket produktivt kvartal, med avsevärda framsteg inom de tre fokusområdena: Partnering, Teknologiutveckling och Förstudien för mRA/LNP-plattformen. Ann Gidner, Ziccums nya VD som tillträdde i maj månad...
27 October, 2022
News
English
Regulatory
Listing Regulation
Report
Interim
Q3
IR
INTERIM REPORT Q3 2022: 1 JANUARY – 30 SEPTEMBER 2022. To read the digital Report, please click here: https://reports-en.ziccum.com/interim-report-q3-2022/start/ Significant events during Q3 (July-September) On July 19, Ziccum published the selected...
24 October, 2022
News
Corporate Information
Other Corporate Information
English
IR
ZICCUM AB (publ) has generated proof of successful nebulization and drying of vaccine lipid nanoparticles (LNP) in its in-house mRNA project. This was carried out using LaminarPaceTM, the company’s ambient drying technology. LNP is the preferred...
27 September, 2022
News
Corporate Information
Other Corporate Information
English
IR
Ziccum AB (publ) (‘Ziccum’) today announces that is has reopened its application process for CEPI’s Call for Proposals (CfP) from companies developing innovative technologies to improve vaccine thermostability. Ziccum will submit an...
23 September, 2022
News
Corporate Information
Other Corporate Information
English
Regulatory
MAR
IR
Ziccum AB (publ) (‘Ziccum’) has today received readout results from the latest stage of an evaluation agreement study carried out with a leading pharmaceutical corporation (previously communicated on June 3, 2022) analyzing LaminarPace’s...
14 September, 2022
News
Corporate Information
Other Corporate Information
English
IR
Following their agreed collaboration, Ziccum AB and the team from the ICP Institute of Computational Physics at the Zurich University of Applied Sciences’s School of Engineering (ZHAW) have now submitted an application to the Eurostars funding body...
01 September, 2022
News
Corporate Information
Other Corporate Information
English
IR
Ziccum AB will be intensifying its partnering and networking dialogues at a series of leading pharma industry events throughout Europe this year. CEO Ann Gidner: “As we strengthen our connections with colleagues throughout the industry, we remain...
23 August, 2022
News
English
Regulatory
Listing Regulation
Report
Interim
Q2
IR
INTERIM REPORT Q2 2022: 1 JANUARY – 30 JUNE 2022. To read the digital Report click here: https://reports-en.ziccum.com/interim-report-q2-2022/ Significant events during Q2 (April-June) Significant events during Q1 (Jan-March) With a new CEO, the...
02 August, 2022
News
Corporate Information
Other Corporate Information
English
IR
Ziccum AB has appointed a Scientific Director, as part of a major reorganisation aiming to facilitate and accelerate its new strategic focus on key projects and vaccine platforms. Ziccum Senior Formulation Specialist Fabrice Rose will assume the new role...
21 July, 2022
News
Corporate Information
Other Corporate Information
English
IR
Ziccum AB, in partnership with the prestigious Zurich University of Applied Sciences, is applying for funding to Eurostars for a joint project developing the 3D modelling of LaminarPace, its unique room-temperature drying system that formulates vaccines...
27 October, 2022
News
English
Regulatory
Listing Regulation
Report
Interim
Q3
IR
INTERIM REPORT Q3 2022: 1 JANUARY – 30 SEPTEMBER 2022. To read the digital Report, please click here: https://reports-en.ziccum.com/interim-report-q3-2022/start/ Significant events during Q3 (July-September) On July 19, Ziccum published the selected...
23 September, 2022
News
Corporate Information
Other Corporate Information
English
Regulatory
MAR
IR
Ziccum AB (publ) (‘Ziccum’) has today received readout results from the latest stage of an evaluation agreement study carried out with a leading pharmaceutical corporation (previously communicated on June 3, 2022) analyzing LaminarPace’s...
23 August, 2022
News
English
Regulatory
Listing Regulation
Report
Interim
Q2
IR
INTERIM REPORT Q2 2022: 1 JANUARY – 30 JUNE 2022. To read the digital Report click here: https://reports-en.ziccum.com/interim-report-q2-2022/ Significant events during Q2 (April-June) Significant events during Q1 (Jan-March) With a new CEO, the...
06 May, 2022
News
Corporate Information
Other Corporate Information
English
Regulatory
Listing Regulation
IR
The Board of Ziccum AB has decided to officially change the company’s language to English for all external market communications as from Friday May 6 2022. Key factors in the decision are that Ziccum has an extensive network of international stakeholders...
06 May, 2022
News
Corporate Information
Other Corporate Information
Swedish
Regulatory
Listing Regulation
IR
Styrelsen för Ziccum AB har beslutat att ändra bolagets språk till engelska för all extern marknadskommunikation från och med fredagen den 6 maj 2022. Viktiga faktorer bakom beslutet är att Ziccum har ett omfattande nätverk...
28 April, 2022
News
Corporate Information
General meeting
Report of the AGM
Swedish
Regulatory
Listing Regulation
IR
Ziccum AB (publ) (”Ziccum”) avhöll den 28 april årsstämma i Lund. Vid stämman fattades bland annat följande beslut. Fastställande av årsbokslut och ansvarsfrihetStämman beslutade att fastställa...
28 April, 2022
News
Swedish
Regulatory
Listing Regulation
Report
Interim
Q1
IR
DELÅRSRAPPORT Q1: 1 JANUARI - 31 MARS 2022 För att läsa hela rapporten digitalt, klicka här: https://reports.ziccum.com/delarsrapport-q1-2022/ Q1 2022 Väsentliga händelser Q1 (jan-mars)På den extra bolagsstämma...
28 April, 2022
News
English
Regulatory
Listing Regulation
Report
Interim
Q1
IR
INTERIM REPORT Q1 2022: 1 JANUARY - 31 MARCH 2022 To read the digital Report click here: https://reports-en.ziccum.com/interim-report-q1-2022/ Q1 2022 Significant events during Q1 (Jan-March)At the Extraordinary General Meeting held on January 18, in...
01 April, 2022
News
Corporate Action
Other
Swedish
Regulatory
Listing Regulation
IR
Tillträdande VD, Ann Gidner och Styrelsens ledamöter Andreas Pettersson samt Kristian Kierkegaard har köpt aktier i Ziccum AB. Ann Gidner, som tillträder sin position som VD den 9 maj har under perioden 29 mars – 1 april köpt...
28 March, 2022
News
Corporate Information
Staff change
English
Regulatory
Listing Regulation
IR
Ann Gidner takes office as new CEO of Ziccum AB on May 9, 2022. Ann has extensive CEO and Business Development experience, driving growth in a wide range of early-stage life science companies. In a global career spanning 25+ years she has held senior...